| Previous Section | Index | Home Page |
10 Oct 2007 : Column 672W—continued
Members: Correspondence
Mr. Baron: To ask the Secretary of State for Health if he will address each of the seven questions asked by the hon. Member for Billericay in the letter to his Department on the subject of testosterone deficiency dated 31 May. [155967]
Ann Keen: A response to this letter was sent to the hon. Member on 19 July 2007. This reply answers all the hon. Member’s questions and there is nothing further we can add to this response.
NHS Next Stage Review
Mr. Lansley: To ask the Secretary of State for Health (1) what his most recent estimate is of the (a) cost to date (i) in total and (ii) broken down by major cost area and (b) expected overall cost to the public purse of Lord Darzi's NHS Next Stage Review; [156415]
(2) what progress Lord Darzi is making in his NHS Next Stage Review; how many (a) clinicians, (b) managers and (c) other staff he has received representations from; how many NHS organisations the review team has formally met with since the announcement of the review; whether he still intends to publish an interim report of the work of the review in October; and if he will make a statement; [156416]
(3) how many clinical pathway groups to inform the work of the NHS Next Stage Review have been established in each strategic health authority; and who the members are of each group which has been established. [156417]
Ann Keen: The interim report, published on 4 October, explains that the review is primarily a local process involving thousands of frontline staff, patients and public in the design of care pathways based on best practice evidence. This is core business for the national health service and as such involves no additional cost to the taxpayer.
The success of a review like this depends of course on the thorough involvement of patients, public and staff and good communication. The total departmental spend so far on staff, patients and public engagement in direct connection with the review is £1.2 million.
The clinicians, managers and other staff leading the review work locally are receiving the great majority of representations from clinicians, managers and other staff.
Lord Darzi personally has met with over 1,500 NHS staff in 17 NHS organisations, read more than 1,400 letters and e-mails from people, including NHS staff, from up and down the country and participated in a nationwide day of detailed discussions with 1,000 people including NHS staff from nine towns and cities. An event attended by representatives of 250 stakeholder groups has been held. In addition, officials at the Department of Health regularly meet with representatives from NHS organisations on various issues right across the span of the review.
Each strategic health authority is responsible for establishing eight local clinical pathway groups. Lists of members should be sought directly from the strategic health authorities themselves.
NHS: ICT
Mr. Stephen O'Brien: To ask the Secretary of State for Health pursuant to the answer of 12 June 2007, Official Report, column 1004W, on NHS: ICT, when the plan of key milestones will be completed; and how it will be made publicly available. [156241]
Mr. Bradshaw: I refer the hon. Member to the answer given on 25 June 2007, Official Report, column 270W.
Skin Cancer: Medical Treatments
Mrs. James: To ask the Secretary of State for Health what estimate he has made of the cost to the NHS of treating skin cancer in each year since 1997; and if he will make a statement. [156446]
Ann Keen: I refer the hon. Member to the answer given on 22 January 2007, Official Report, columns 1605-06W.
Foreign and Commonwealth Office
British Overseas Territories
Andrew Mackinlay: To ask the Secretary of State for Foreign and Commonwealth Affairs whether the UK's obligations under the UN Convention on the Elimination of all Forms of Discrimination against Women have been extended to all UK overseas territories; and if he will make a statement. [155813]
Meg Munn:
The Government are working to encourage the extension of the UK's obligation under the UN Convention on the Elimination of Discrimination against Women to all the UK populated Overseas Territories. With the agreement of the respective territory governments,
we have extended this convention to the British Virgin Islands, the Falkland Islands and the Turks and Caicos Islands.
The Cayman Islands Government have formally requested that the Convention on the Elimination of Discrimination Against Women should be extended to them. Further legislative work is ongoing and will need to be completed before the Convention can be extended. The Governments of Bermuda and Gibraltar have also agreed to draft legislation to enable the Convention on the Elimination of Discrimination Against Women to be extended to them.
We will continue to encourage those UK Overseas Territories that have not yet agreed to the extension of the Convention on the Elimination of Discrimination Against Women to do so.
Departments: European Indicators Project
Ms Gisela Stuart: To ask the Secretary of State for Foreign and Commonwealth Affairs what steps his Department is taking to ensure full participation in the European Indicators Project by official bodies and UK assessment organisations. [154221]
Mr. Jim Murphy: I refer my hon. Friend to the reply my hon. Friend the Minister for Schools and Learners, Jim Knight, gave to her on 8 October 2007, Official Report, columns 382-83W.
Entry Clearances
Stephen Williams: To ask the Secretary of State for Foreign and Commonwealth Affairs what percentage of appeals against a refusal to issue a visa were upheld in the last 12 months, broken down by overseas post. [156669]
Dr. Howells: I refer the hon. Member to the following table.
| Next Section | Index | Home Page |